Ron Wooten, Founding Partner, of NovaQuest has over 25 years of healthcare investing experience is currently the CIO of NovaQuest Capital Management. He also heads the investment committee of the General Partner of NovaQuest Pharma Opportunities Fund III and IV. His responsibilities include management company oversight, investment policy, fundraising, and the day-to-day management of the NovaQuest Pharma Opportunities business.
Since its formation in 2000 through November 2010, while NQ was a business unit within Quintiles; Mr. Wooten led the platform in creating and managing unique relationships, structured finance and equity investments with more than $2 billion in gross commitments, capital or services to companies of all sizes. He was also an Executive Vice President of Quintiles and managed their customer-partnering arrangements worldwide. He also served on the Quintiles Board of Directors from January 2008 through November 2010.
Mr. Wooten’s previous experience includes nine years with First Union Securities, where he served as a Managing Director of Investment Banking focusing on M&A transactions across the middle market. Before he started his career in finance, he was a member of the New England Patriots football team from 1981 to 1990.
Mr. Wooten received his Bachelor’s degree in Chemistry from the University of North Carolina at Chapel Hill and earned an MBA from Boston University.